AstraZeneca, GB0009895292

AstraZeneca stock has ESMO event today ahead of the Xetra open

Published on 10/26/2026 at 08:30 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
AstraZeneca’s calendar lists 9M and Q3 2026 results for October 30, 2026. At Lang & Schwarz the stock trades pre-market at EUR 154.28 on October 26, 2026.

ESMO event and results date

  • AstraZeneca’s investor calendar lists an ESMO management event for October 26, 2026 at 2:30 p.m. EDT.
  • The company’s 9M and Q3 2026 results are scheduled for October 30, 2026.
  • AstraZeneca stock trades pre-market at EUR 154.28 at 8:28 a.m. CET at Lang & Schwarz on October 26, 2026.
AstraZeneca plc (ISIN GB0009895292) steuert eine komplexe Wertschöpfungskette von Forschung bis zur globalen Arzneimittel-Distribution, Illustration mit AI erstellt.

AstraZeneca’s investor-relations calendar lists an ESMO 2026 Meet the Management event for October 26, 2026, at 2:30 p.m. EDT. The same calendar lists the company’s 9M and Q3 2026 results for October 30, 2026. AstraZeneca stock trades pre-market at EUR 154.28 at 8:28 a.m. CET at Lang & Schwarz on October 26, 2026.

ESMO event on October 26

The event is listed as taking place in Madrid in a hybrid format, with management participation, according to AstraZeneca’s investor-relations calendar. The calendar gives the event time as 18:30 GMT and 19:30 CEST.

Ahead of the Xetra open

The price indication from Lang & Schwarz is EUR 154.28 at 8:28 a.m. CET. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of AstraZeneca stock.

What is on the calendar

AstraZeneca’s investor-relations calendar identifies October 30, 2026, as the date for its 9M and Q3 2026 results. Market context: Market report FTSE 100.

More news and analysis on AstraZeneca stock

Disclaimer...
en | GB0009895292 | ASTRAZENECA | boerse | 70412885 | bgmi